Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.15
OCR's Cash to Debt is ranked lower than
61% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. OCR: 0.15 )
Ranked among companies with meaningful Cash to Debt only.
OCR' s 10-Year Cash to Debt Range
Min: 0.05  Med: 0.15 Max: 67.66
Current: 0.15
0.05
67.66
Equity to Asset 0.41
OCR's Equity to Asset is ranked lower than
52% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. OCR: 0.41 )
Ranked among companies with meaningful Equity to Asset only.
OCR' s 10-Year Equity to Asset Range
Min: 0.31  Med: 0.50 Max: 0.88
Current: 0.41
0.31
0.88
F-Score: 6
Z-Score: 3.29
M-Score: -2.77
WACC vs ROIC
1.85%
5.54%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.23
OCR's Operating margin (%) is ranked lower than
54% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 7.05 vs. OCR: 6.23 )
Ranked among companies with meaningful Operating margin (%) only.
OCR' s 10-Year Operating margin (%) Range
Min: 3.14  Med: 7.98 Max: 11.55
Current: 6.23
3.14
11.55
Net-margin (%) 2.57
OCR's Net-margin (%) is ranked lower than
55% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 3.29 vs. OCR: 2.57 )
Ranked among companies with meaningful Net-margin (%) only.
OCR' s 10-Year Net-margin (%) Range
Min: -1.76  Med: 3.36 Max: 6.75
Current: 2.57
-1.76
6.75
ROE (%) 6.58
OCR's ROE (%) is ranked lower than
58% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 8.45 vs. OCR: 6.58 )
Ranked among companies with meaningful ROE (%) only.
OCR' s 10-Year ROE (%) Range
Min: -2.76  Med: 5.79 Max: 13.17
Current: 6.58
-2.76
13.17
ROA (%) 2.71
OCR's ROA (%) is ranked lower than
53% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 3.44 vs. OCR: 2.71 )
Ranked among companies with meaningful ROA (%) only.
OCR' s 10-Year ROA (%) Range
Min: -1.44  Med: 2.83 Max: 8
Current: 2.71
-1.44
8
ROC (Joel Greenblatt) (%) 33.93
OCR's ROC (Joel Greenblatt) (%) is ranked higher than
69% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 15.83 vs. OCR: 33.93 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OCR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 11.67  Med: 28.38 Max: 89.75
Current: 33.93
11.67
89.75
Revenue Growth (3Y)(%) 3.90
OCR's Revenue Growth (3Y)(%) is ranked lower than
66% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. OCR: 3.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OCR' s 10-Year Revenue Growth (3Y)(%) Range
Min: -0.4  Med: 11.10 Max: 40.5
Current: 3.9
-0.4
40.5
EBITDA Growth (3Y)(%) 2.20
OCR's EBITDA Growth (3Y)(%) is ranked lower than
74% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. OCR: 2.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OCR' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -8.8  Med: 6.50 Max: 37.6
Current: 2.2
-8.8
37.6
EPS Growth (3Y)(%) 7.30
OCR's EPS Growth (3Y)(%) is ranked lower than
55% of the 115 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. OCR: 7.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OCR' s 10-Year EPS Growth (3Y)(%) Range
Min: -49.6  Med: 4.90 Max: 86.6
Current: 7.3
-49.6
86.6
» OCR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

OCR Guru Trades in Q2 2014

Joel Greenblatt 48,646 sh (+1336.68%)
Pioneer Investments 689,748 sh (+33.81%)
James Barrow 4,996,755 sh (+4.09%)
First Eagle Investment 844,500 sh (-0.21%)
Chuck Royce 56,599 sh (-5.67%)
Jim Simons 454,900 sh (-5.68%)
Paul Tudor Jones 100,564 sh (-56.72%)
» More
Q3 2014

OCR Guru Trades in Q3 2014

Ray Dalio 5,634 sh (New)
Joel Greenblatt 501,043 sh (+929.98%)
Jim Simons 1,125,800 sh (+147.48%)
James Barrow 5,059,633 sh (+1.26%)
First Eagle Investment 844,500 sh (unchged)
Pioneer Investments 705,443 sh (unchged)
Paul Tudor Jones Sold Out
Chuck Royce 52,399 sh (-7.42%)
» More
Q4 2014

OCR Guru Trades in Q4 2014

Louis Moore Bacon 165,000 sh (New)
Jim Simons 1,531,600 sh (+36.05%)
First Eagle Investment 844,500 sh (unchged)
Joel Greenblatt Sold Out
Ray Dalio Sold Out
Chuck Royce 51,199 sh (-2.29%)
James Barrow 4,807,769 sh (-4.98%)
Pioneer Investments 636,307 sh (-9.80%)
» More
Q1 2015

OCR Guru Trades in Q1 2015

Joel Greenblatt 337,773 sh (New)
First Eagle Investment 844,500 sh (unchged)
Louis Moore Bacon Sold Out
Chuck Royce Sold Out
James Barrow 4,801,304 sh (-0.13%)
Pioneer Investments 629,794 sh (-1.02%)
Jim Simons 698,100 sh (-54.42%)
» More
» Details

Insider Trades

Latest Guru Trades with OCR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 74.60
OCR's P/E(ttm) is ranked lower than
87% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 29.60 vs. OCR: 74.60 )
Ranked among companies with meaningful P/E(ttm) only.
OCR' s 10-Year P/E(ttm) Range
Min: 10.93  Med: 25.53 Max: 122.41
Current: 74.6
10.93
122.41
Forward P/E 20.83
OCR's Forward P/E is ranked lower than
54% of the 92 Companies
in the Global Medical Care industry.

( Industry Median: 20.37 vs. OCR: 20.83 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 73.90
OCR's PE(NRI) is ranked lower than
87% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 29.10 vs. OCR: 73.90 )
Ranked among companies with meaningful PE(NRI) only.
OCR' s 10-Year PE(NRI) Range
Min: 9.68  Med: 25.09 Max: 639.6
Current: 73.9
9.68
639.6
P/B 3.68
OCR's P/B is ranked lower than
62% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 2.73 vs. OCR: 3.68 )
Ranked among companies with meaningful P/B only.
OCR' s 10-Year P/B Range
Min: 0.6  Med: 1.19 Max: 3.69
Current: 3.68
0.6
3.69
P/S 1.50
OCR's P/S is ranked higher than
50% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. OCR: 1.50 )
Ranked among companies with meaningful P/S only.
OCR' s 10-Year P/S Range
Min: 0.33  Med: 0.68 Max: 1.55
Current: 1.5
0.33
1.55
PFCF 21.38
OCR's PFCF is ranked higher than
52% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 21.92 vs. OCR: 21.38 )
Ranked among companies with meaningful PFCF only.
OCR' s 10-Year PFCF Range
Min: 4.79  Med: 10.79 Max: 71.06
Current: 21.38
4.79
71.06
POCF 18.84
OCR's POCF is ranked lower than
59% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 15.63 vs. OCR: 18.84 )
Ranked among companies with meaningful POCF only.
OCR' s 10-Year POCF Range
Min: 4.29  Med: 9.27 Max: 50.64
Current: 18.84
4.29
50.64
EV-to-EBIT 27.11
OCR's EV-to-EBIT is ranked lower than
66% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 20.07 vs. OCR: 27.11 )
Ranked among companies with meaningful EV-to-EBIT only.
OCR' s 10-Year EV-to-EBIT Range
Min: 8.7  Med: 15.80 Max: 30.5
Current: 27.11
8.7
30.5
PEG 22.39
OCR's PEG is ranked lower than
97% of the 65 Companies
in the Global Medical Care industry.

( Industry Median: 2.89 vs. OCR: 22.39 )
Ranked among companies with meaningful PEG only.
OCR' s 10-Year PEG Range
Min: 0.67  Med: 2.01 Max: 2547
Current: 22.39
0.67
2547
Shiller P/E 118.58
OCR's Shiller P/E is ranked lower than
90% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 31.19 vs. OCR: 118.58 )
Ranked among companies with meaningful Shiller P/E only.
OCR' s 10-Year Shiller P/E Range
Min: 9.36  Med: 27.19 Max: 117.22
Current: 118.58
9.36
117.22
Current Ratio 1.65
OCR's Current Ratio is ranked higher than
64% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. OCR: 1.65 )
Ranked among companies with meaningful Current Ratio only.
OCR' s 10-Year Current Ratio Range
Min: 0.9  Med: 3.37 Max: 9.8
Current: 1.65
0.9
9.8
Quick Ratio 1.18
OCR's Quick Ratio is ranked higher than
50% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. OCR: 1.18 )
Ranked among companies with meaningful Quick Ratio only.
OCR' s 10-Year Quick Ratio Range
Min: 0.73  Med: 2.76 Max: 9.04
Current: 1.18
0.73
9.04
Days Inventory 33.05
OCR's Days Inventory is ranked lower than
68% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 17.87 vs. OCR: 33.05 )
Ranked among companies with meaningful Days Inventory only.
OCR' s 10-Year Days Inventory Range
Min: 30.61  Med: 34.45 Max: 39.1
Current: 33.05
30.61
39.1
Days Sales Outstanding 33.96
OCR's Days Sales Outstanding is ranked higher than
73% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 46.60 vs. OCR: 33.96 )
Ranked among companies with meaningful Days Sales Outstanding only.
OCR' s 10-Year Days Sales Outstanding Range
Min: 32.92  Med: 73.78 Max: 98.27
Current: 33.96
32.92
98.27

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.89
OCR's Dividend Yield is ranked lower than
77% of the 226 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. OCR: 0.89 )
Ranked among companies with meaningful Dividend Yield only.
OCR' s 10-Year Dividend Yield Range
Min: 0.15  Med: 0.40 Max: 1.32
Current: 0.89
0.15
1.32
Dividend Payout 0.53
OCR's Dividend Payout is ranked lower than
58% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 0.64 vs. OCR: 0.53 )
Ranked among companies with meaningful Dividend Payout only.
OCR' s 10-Year Dividend Payout Range
Min: 0.03  Med: 0.10 Max: 0.95
Current: 0.53
0.03
0.95
Dividend growth (3y) 75.00
OCR's Dividend growth (3y) is ranked higher than
97% of the 64 Companies
in the Global Medical Care industry.

( Industry Median: 10.10 vs. OCR: 75.00 )
Ranked among companies with meaningful Dividend growth (3y) only.
OCR' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 4.00 Max: 78
Current: 75
0
78
Yield on cost (5-Year) 10.46
OCR's Yield on cost (5-Year) is ranked higher than
95% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 2.03 vs. OCR: 10.46 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
OCR' s 10-Year Yield on cost (5-Year) Range
Min: 1.76  Med: 4.70 Max: 15.52
Current: 10.46
1.76
15.52
Share Buyback Rate 2.50
OCR's Share Buyback Rate is ranked higher than
93% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. OCR: 2.50 )
Ranked among companies with meaningful Share Buyback Rate only.
OCR' s 10-Year Share Buyback Rate Range
Min: 2.5  Med: -2.10 Max: -11
Current: 2.5

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) (%) 3.70
OCR's Earnings Yield (Greenblatt) (%) is ranked lower than
52% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. OCR: 3.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OCR' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 3.3  Med: 6.30 Max: 11.5
Current: 3.7
3.3
11.5
Forward Rate of Return (Yacktman) (%) 14.14
OCR's Forward Rate of Return (Yacktman) (%) is ranked higher than
62% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 11.00 vs. OCR: 14.14 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
OCR' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 3.2  Med: 9.80 Max: 24.3
Current: 14.14
3.2
24.3

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:OMN.Germany,
Omnicare Inc was formed in 1981 in Delaware. It is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group and Specialty Care Group. Through Long-Term Care Group, the Company provides pharmaceuticals and related pharmacy services to long-term care facilities as well as chronic care facilities and other settings. Through Specialty Care Group, the Company provides specialty pharmacy and commercialization services for the biopharmaceutical industry. The Company's businesses engage in an ongoing program for the development and marketing of new services. The Company serves long-term care institutions and other chronic care settings in approximately 47 states in the U.S. and the District of Columbia. The Company's largest competitor nationally is PharMerica Corporation. It also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. The Company is subject to extensive federal, state and local regulation.
» More Articles for OCR

Headlines

Articles On GuruFocus.com
Mario Gabelli's ABC Fund Merger and Arbitrage 'The Deal Fund' Q2 Commentary Jul 23 2015 
CVS Eyeing Omnicare Acquisition To Bolster Market Position May 23 2015 
CVS To Buy Out Omnicare For $10.4 Billion May 22 2015 
Glenview Capital Raises Stake In Monsanto May 21 2015 
phone Dec 18 2014 
It's Time to Follow Chris Davis and Buy Laboratory Corp Jan 15 2014 
Steven Romick’s Third Quarter Sells at FPA Crescent Fund Oct 17 2013 
Waiting for Gold Rain, Wally Weitz Does "Unnaturally Well" Sep 23 2013 
First Pacific Advisors’ Major Selling and Reductions in Second Quarter Aug 15 2013 
Steven Romick Comments on Omnicare Jul 29 2013 

More From Other Websites
European stocks close higher Jul 31 2015
OMNICARE INC Financials Jul 30 2015
OMNICARE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 29 2015
JP Morgan Downgrades Omnicare Following CVS Deal Jul 27 2015
10-Q for Omnicare, Inc. Jul 26 2015
Omnicare downgraded by JP Morgan Jul 24 2015
Omnicare Reports Second-Quarter 2015 Financial Results Jul 24 2015
Omnicare beats 2Q profit forecasts Jul 24 2015
Omnicare beats 2Q profit forecasts Jul 24 2015
OMNICARE INC Files SEC form 8-K, Results of Operations and Financial Condition Jul 24 2015
Omnicare Reports Second-Quarter 2015 Financial Results Jul 24 2015
Q2 2015 Omnicare Inc Earnings Release - Before Market Open Jul 24 2015
Omnicare Reports Second-Quarter 2015 Financial Results Jul 24 2015
CVS Goes Shopping: Financing the Target Purchase Jul 21 2015
Omnicare agrees to settle federal kickback lawsuit Jul 13 2015
Omnicare to Report Second-Quarter 2015 Financial Results on Friday, July 24, 2015 Jul 10 2015
Omnicare to Report Second-Quarter 2015 Financial Results on Friday, July 24, 2015 Jul 10 2015
McKesson Sees Healthy Growth In Prescription Drugs Jun 25 2015
Pittsburgh Business Group on Health-CVS contract could save members $75M on drug costs Jun 25 2015
CVS President Helena Foulkes on how a tobacco-free CVS plans to make up $2B in lost revenue Jun 23 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK